Push for progress: what the rare diseases framework extension means for patients and the future of UK innovation
The development represents a test of whether rare disease policy can be fully integrated into the health systems transformation agenda....
GLP-1s: what is behind the variation in efficacy?
Researchers are trying to untangle the roles of genetics, access and treatment persistence in the efficacy of GLP-1s. As evidence...
NHS England to review guidance for pain management in ketamine users following patient death
The Dorset coroner expressed concern that there were no prescribing guidelines for analgesia in patients with ketamine bladder syndrome who...
Large areas of England do not commission enough childhood asthma tests
Research by charity Asthma + Lung UK found that 35% of integrated care systems did not have a dedicated respiratory...
Healthcare professionals will receive ‘clear and scalable psychological support in a future pandemic, government says
Lack of data on COVID-19 staff deaths was seen as a reflection that healthcare workers were not being counted or...
Anti-racism requirements should be mandated across AI, says NHS race body
Report produced following roundtable attended by government, NHS England and the Patients Association warns systems can entrench, amplify and scale...